Literature DB >> 34283020

What if melatonin could help patients with severe COVID-19?

Miguel Ángel Sánchez-González1,2, Ignacio Mahíllo-Fernández3, Felipe Villar-Álvarez4, Lucía Llanos5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34283020      PMCID： PMC8807901          DOI： 10.5664/jcsm.9554

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  11 in total

1.  Can melatonin reduce the severity of COVID-19 pandemic?

Authors:  Alex Shneider; Aleksandr Kudriavtsev; Anna Vakhrusheva
Journal:  Int Rev Immunol       Date:  2020-04-29       Impact factor: 5.311

2.  Circadian Gene Expression Rhythms During Critical Illness.

Authors:  Matthew B Maas; Marta Iwanaszko; Bryan D Lizza; Kathryn J Reid; Rosemary I Braun; Phyllis C Zee
Journal:  Crit Care Med       Date:  2020-12       Impact factor: 9.296

Review 3.  Melatonin: Pharmacology, Functions and Therapeutic Benefits.

Authors:  Sylvie Tordjman; Sylvie Chokron; Richard Delorme; Annaëlle Charrier; Eric Bellissant; Nemat Jaafari; Claire Fougerou
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

Review 4.  Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?

Authors:  Fedor Simko; Russel J Reiter
Journal:  Life Sci       Date:  2020-06-03       Impact factor: 5.037

5.  Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting.

Authors:  Guillermo Rodriguez-Nava; Maria Adriana Yanez-Bello; Daniela Patricia Trelles-Garcia; Chul Won Chung; Harvey J Friedman; David W Hines
Journal:  Int J Infect Dis       Date:  2020-11-09       Impact factor: 3.623

Review 6.  Melatonin potentials against viral infections including COVID-19: Current evidence and new findings.

Authors:  Kobra Bahrampour Juybari; Mohammad Hossein Pourhanifeh; Azam Hosseinzadeh; Karim Hemati; Saeed Mehrzadi
Journal:  Virus Res       Date:  2020-08-05       Impact factor: 3.303

Review 7.  COVID-19: Melatonin as a potential adjuvant treatment.

Authors:  Rui Zhang; Xuebin Wang; Leng Ni; Xiao Di; Baitao Ma; Shuai Niu; Changwei Liu; Russel J Reiter
Journal:  Life Sci       Date:  2020-03-23       Impact factor: 5.037

8.  Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.

Authors:  Ava Ziaei; Parivash Davoodian; Habib Dadvand; Omid Safa; Soheil Hassanipour; Mahmoud Omidi; Moein Masjedi; Fahime Mahmoudikia; Bahareh Rafiee; Mohammad Fathalipour
Journal:  Trials       Date:  2020-10-26       Impact factor: 2.279

9.  Clinical trial to test the efficacy of melatonin in COVID-19.

Authors:  Dario Acuña-Castroviejo; Germaine Escames; Juan C Figueira; Pedro de la Oliva; Alberto M Borobia; Carlos Acuña-Fernández
Journal:  J Pineal Res       Date:  2020-08-08       Impact factor: 13.007
View more
  2 in total

Review 1.  Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality.

Authors:  Dun-Xian Tan; Russel J Reiter
Journal:  Life Sci       Date:  2022-01-30       Impact factor: 6.780

2.  Melatonin use for SARS-CoV-2 infection: Time to diversify the treatment portfolio.

Authors:  Russel J Reiter; Ramaswamy Sharma; Dun-Xian Tan; Richard L Neel; Fedor Simko; Walter Manucha; Sergio Rosales-Corral; Daniel P Cardinali
Journal:  J Med Virol       Date:  2022-04-12       Impact factor: 20.693
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.